OTCMKTS:MSLP - MusclePharm Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$0.58 0.00 (0.00 %)
(As of 03/18/2019 11:52 AM ET)
Previous Close$0.58
Today's Range$0.58 - $0.6450
52-Week Range$0.2960 - $1.43
Volume783 shs
Average Volume20,150 shs
Market Capitalization$9.44 million
P/E RatioN/A
Dividend YieldN/A
MusclePharm Corporation develops, manufactures, markets, and distributes nutritional supplements in the United States and internationally. It offers a range of powders, capsules, tablets, and gels. The company's MusclePharm brand product portfolio include Combat protein powder and Combat crunch protein bars; essentials supplements, such as a BCAA, creatine, glutamine, carnitine, CLA, fish oil, multi-vitamin, and other products; and non-genetically modified organism sports performance products with organic ingredients, plant-based proteins, and natural caffeine sources for use in the various stages of the workout. It also provides FitMiss sports nutrition products, which are designed and formulated primarily for women lifestyle to cover various needs, including weight management, lean muscle mass, body composition, and general health and wellness. MusclePharm Corporation sells its products to various fitness enthusiasts, such as professional, combat sport, weight training, bodybuilding, running, and various team and individual sports, as well as individuals who lead an active lifestyle. The company was founded in 2006 and is headquartered in Burbank, California.

Receive MSLP News and Ratings via Email

Sign-up to receive the latest news and ratings for MSLP and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
SectorConsumer Staples
Current SymbolOTCMKTS:MSLP



Sales & Book Value

Annual Sales$102.15 million
Book Value($0.86) per share


Net Income$-10,970,000.00


Market Cap$9.44 million
Next Earnings Date3/27/2019 (Estimated)
OptionableNot Optionable

MusclePharm (OTCMKTS:MSLP) Frequently Asked Questions

What is MusclePharm's stock symbol?

MusclePharm trades on the OTCMKTS under the ticker symbol "MSLP."

How were MusclePharm's earnings last quarter?

MusclePharm Corp (OTCMKTS:MSLP) issued its quarterly earnings data on Monday, August, 10th. The company reported ($0.51) EPS for the quarter, missing the Thomson Reuters' consensus estimate of ($0.19) by $0.32. The firm earned $50.48 million during the quarter, compared to the consensus estimate of $55 million. View MusclePharm's Earnings History.

When is MusclePharm's next earnings date?

MusclePharm is scheduled to release their next quarterly earnings announcement on Wednesday, March 27th 2019. View Earnings Estimates for MusclePharm.

Has MusclePharm been receiving favorable news coverage?

Media stories about MSLP stock have trended somewhat positive recently, InfoTrie Sentiment reports. The research group identifies negative and positive news coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. MusclePharm earned a coverage optimism score of 1.1 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an impact on the company's share price in the near future.

Who are some of MusclePharm's key competitors?

What other stocks do shareholders of MusclePharm own?

Based on aggregate information from My MarketBeat watchlists, some companies that other MusclePharm investors own include EVRAZ (EVRZF), Rent-A-Center (RCII), Dalradian Resources (DALR), Harte Hanks (HHS), Accuray (ARAY), The Western Union (WU), WNS (WNS), Essex Property Trust (ESS), AdvanSix (ASIX) and Talktalk Telecom Group (TALK).

Who are MusclePharm's key executives?

MusclePharm's management team includes the folowing people:
  • Mr. Ryan Charles Drexler, Exec. Chairman, CEO & Pres (Age 48)
  • Mr. Brian Casutto, Exec. VP of Sales & Operations and Director (Age 48)
  • John Mills Mills, Sr. Managing Director
  • Mr. Kevin R. Harris, Interim Chief Financial Officer (Age 50)
  • Dr. Roscoe M. Moore Jr., DVM, Ph.D., MPH, DSc, Chief Scientific Director and Member of Scientific Advisory Board (Age 65)

How do I buy shares of MusclePharm?

Shares of MSLP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is MusclePharm's stock price today?

One share of MSLP stock can currently be purchased for approximately $0.58.

How big of a company is MusclePharm?

MusclePharm has a market capitalization of $9.44 million and generates $102.15 million in revenue each year. MusclePharm employs 56 workers across the globe.

What is MusclePharm's official website?

The official website for MusclePharm is http://www.musclepharm.com.

How can I contact MusclePharm?

MusclePharm's mailing address is 4400 VANOWEN STREET, BURBANK CA, 91505. The company can be reached via phone at 800-292-3909 or via email at [email protected]

MarketBeat Community Rating for MusclePharm (OTCMKTS MSLP)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  68 (Vote Outperform)
Underperform Votes:  72 (Vote Underperform)
Total Votes:  140
MarketBeat's community ratings are surveys of what our community members think about MusclePharm and other stocks. Vote "Outperform" if you believe MSLP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MSLP will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 3/18/2019 by MarketBeat.com Staff

Featured Article: What are the FAANG Stocks?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel